Yield10 Bioscience induces exercise of 3.19M warrants at $0.43/share, issues 6.38M new warrants

YIELD10 BIOSCIENCE, INC.

Existing institutional investors exercise 3,191,140 warrants for cash at reduced exercise price of $0.43 per share.
Company issues new unregistered warrants to purchase up to 6,382,280 shares (200% of exercised shares) at $0.43/share.
New warrants exercisable for five years from shareholder approval date, subject to 9.99% beneficial ownership limitation.
Company to seek shareholder approval within 90 days for issuance of new warrants and underlying shares.
Maxim Group LLC acting as warrant solicitation agent; receives 7.0% cash fee on total proceeds from exercised warrants.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

YIELD10 BIOSCIENCE, INC. entered into Agreements with certain existing institutional investors (effective 2024-03-22).

Action: entry
Agreement: equity purchase
Counterparty: certain existing institutional investors
Effective: 2024-03-22

Exact text from the filing

On March 22, 2024, Yield10 Bioscience, Inc., a Delaware corporation (the “ Company ”), entered into warrant exercise agreements (the “ Agreements ”) with certain existing institutional investors

View on SEC.gov

547 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0001104659-24-037635

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.